Gross Profit Comparison: Johnson & Johnson and Bausch Health Companies Inc. Trends

Johnson & Johnson's decade-long gross profit dominance over Bausch Health.

__timestampBausch Health Companies Inc.Johnson & Johnson
Wednesday, January 1, 2014600890000051585000000
Thursday, January 1, 2015785380000048538000000
Friday, January 1, 2016706300000050205000000
Sunday, January 1, 2017617600000051096000000
Monday, January 1, 2018602900000054490000000
Tuesday, January 1, 2019625100000054503000000
Wednesday, January 1, 2020577800000054157000000
Friday, January 1, 2021604000000055338000000
Saturday, January 1, 2022576000000055394000000
Sunday, January 1, 2023619800000058606000000
Monday, January 1, 202433879000000
Loading chart...

Unleashing insights

A Decade of Gross Profit Trends: Johnson & Johnson vs. Bausch Health

In the ever-evolving landscape of the healthcare industry, the financial performance of giants like Johnson & Johnson and Bausch Health Companies Inc. offers a fascinating glimpse into their strategic maneuvers. Over the past decade, Johnson & Johnson has consistently outperformed Bausch Health in terms of gross profit, showcasing a robust growth trajectory. From 2014 to 2023, Johnson & Johnson's gross profit surged by approximately 14%, peaking in 2023. In contrast, Bausch Health experienced a more volatile journey, with a notable peak in 2015, followed by fluctuations and a modest recovery by 2023.

This comparison highlights Johnson & Johnson's resilience and strategic prowess, maintaining a gross profit nearly eight times that of Bausch Health in 2023. As the healthcare sector continues to face challenges and opportunities, these trends underscore the importance of strategic innovation and market adaptation.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025